- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00325663
Acupuncture in Osteoarthritis of the Knee
Specific and Non-Specific Effects of Acupuncture: A Double-Blinded, Randomized, Controlled Trial in Patients With Osteoarthritis of the Knee
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Acupuncture is one of the most frequently used complementary therapeutic approaches in the treatment of osteoarthritis of the knee. Due to methodological shortcomings of previous randomized controlled studies, controversy persists whether the observed effects are specific to acupuncture or non-specific consequences of needling.
Objective: To compare classical Chinese acupuncture, semi-standardized modern acupuncture and non-specific needling by means of a double-blinded repeated measures cross-over design.
Intervention: Within three weeks all patients receive three treatment modalities in a random order in a double-blind study design.
Main outcome measures: Improvement in knee flexibility according to the neutral-zero method, defining a success as improvement by 10 degrees or more.
Secondary parameter: improvement in pain according to the reduced WOMAC score by 50 percent or more.
Study Type
Enrollment
Phase
- Phase 2
- Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients above age 35
- knee osteoarthritis grade II or III according to the Kellgren classification.
Exclusion Criteria:
- orthopedic deformations of the knee,
- malignant disease
- auto-immune disorders
- surgery including arthroscopy during the past 12 months
- pain medication with steroids
- physical therapy or acupuncture within the last for weeks
- no or a pain medication in continuous dosage
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Main outcome measures: Improvement in knee flexibility according to the neutral-zero method, defining a success as improvement by 10 degrees or more.
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Secondary parameter: improvement in pain according to the reduced WOMAC score by 50 percent or more.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Max Karner, MD, University Heidelberg
- Study Director: Johannes Greten, MD, German Society of Traditional Chinese Medicine
- Study Chair: Oliver Gerlach, MD, Shen-Centre for Traditional Chinese Medicine, Erlangen, Germany
- Study Chair: Frank Brazkiewicz, MD, Centre for Chinese Medicine, Bremen, Germany
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AKOK1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.